Oxybutynin Chloride
Product Images NDC 68151-3646

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Oxybutynin Chloride (NDC 68151-3646). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Carilion Materials Management, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl681513646)

This is a description of Oxybutynin Chloride Extended-Release tablets manufactured by IMPAX. Each tablet contains 5mg of the medication and is intended for prescription use only. The lot number is 10007041 and the expiration date is 09/14. The code "W0311143m6" is also present but its meaning is unknown.*

FDA Label Image

Chemical Structure (Oxybutynin Chloride Extended Release Tablets 1)

FDA Label Image

Figure 1 (Oxybutynin Chloride Extended Release Tablets 2)

FDA Label Image

Figure 2 (Oxybutynin Chloride Extended Release Tablets 3)

FDA Label Image

Figure (Oxybutynin Chloride Extended Release Tablets 4)

The text is a graph showing the mean change in episodes per week from baseline for Oxybutynin Chloride Extended-Release Tablets compared to a placebo. There is no further information available from the given text.*

FDA Label Image

Figure (Oxybutynin Chloride Extended Release Tablets 5)

FDA Label Image

Figure (Oxybutynin Chloride Extended Release Tablets 6)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.